Detalhe da pesquisa
1.
Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels.
Gastroenterology
; 164(4): 669-679.e6, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642151
2.
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion.
Clin Gastroenterol Hepatol
; 22(3): 581-590.e6, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871842
3.
Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy.
J Formos Med Assoc
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423922
4.
Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months.
Hepatol Res
; 53(10): 1021-1030, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37291079
5.
Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy.
J Formos Med Assoc
; 122(7): 564-573, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872131
6.
Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection.
J Formos Med Assoc
; 122(10): 1008-1017, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37147239
7.
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase.
Am J Gastroenterol
; 117(5): 748-757, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191399
8.
High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
Gastroenterology
; 157(6): 1518-1529.e3, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31470004
9.
Gastrointestinal complications are associated with a poor outcome in non-critically ill pneumonia patients.
BMC Gastroenterol
; 20(1): 383, 2020 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33198635
10.
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection.
J Gastroenterol Hepatol
; 34(9): 1620-1625, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30693965
11.
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.
J Gastroenterol Hepatol
; 34(12): 2179-2186, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31062879
12.
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients With Chronic Hepatitis C Virus Infection.
Clin Infect Dis
; 66(2): 289-292, 2018 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29020359
13.
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan.
J Gastroenterol Hepatol
; 33(3): 710-717, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28762541
14.
A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients.
J Gastroenterol Hepatol
; 33(1): 291-297, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28548299
15.
Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response.
J Formos Med Assoc
; 116(4): 295-299, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28034492
16.
Liver dysfunction and clinical outcomes of unvaccinated COVID-19 patients with and without chronic hepatitis B.
J Microbiol Immunol Infect
; 57(1): 55-63, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110321
17.
HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative.
JHEP Rep
; 6(1): 100956, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38089551
18.
High PIVKA-II level and ASAP score predict 1-year risk of hepatocellular carcinoma in non-cirrhotic chronic hepatitis B patients.
Am J Cancer Res
; 13(6): 2588-2597, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37424806
19.
Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease.
Gut Pathog
; 15(1): 24, 2023 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37218009
20.
Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B.
Hepatol Int
; 17(5): 1139-1149, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247045